CPTx is a leader in developing the next generation of non-viral, DNA-based in vivo CAR T cell therapies, uniquely overcoming key challenges in both oncology and autoimmune disease. CPTx’s immune-quiet proprietary DNA platform enables control over the duration of gene expression from transient to permanent, supports the co-delivery of multiple genes, and allows for repeat administration.
| Website | https://www.cptx.bio |
| Employees | 49 (35 on RocketReach) |
| Founded | 2021 |
| Address | Semmelweisstraße 1, Planegg, Bavaria 82152, DE |
| Phone | +49 89 69330382 |
| Industry | Biotechnology Research |
| Keywords | Therapeutic Discovery, Nanomedicine, Drug Development, Ai Driven Design, Therapeutic Agents, Drug Delivery, Novel Therapeutics, Biotechnology, Targeted Therapy, Innovative Treatments, Advanced Therapeutics, Precision Medicine, Pharmaceutical Research, Biomedical Engineering, Personalized Medicine, Gene Therapy |
| Competitors | Pfizer, AstraZeneca, Genentech, Amgen, Moderna Therapeutics, Novavax, CureVac, Zymeworks Inc., Zymergen, Inc., iBio, Inc. +43 more (view full list) |
Looking for a particular CPTx employee's phone or email?
Christian Sigl is the Co-Founder of CPTx.
35 people are employed at CPTx.
CPTx is based in Planegg, Bavaria.